Industry Supported Sessions


13:15-14:45                              PADIGLIONE CAVANIGLIA  HALL B  


Negative Symptoms of Schizophrenia – Facts and Challenges

Chair:              René Kahn, USA

13:15 – 13:30  Welcome                                                                     René Kahn, USA

13:30 – 14:00  Definition, diagnosis and prevalence of negative symptoms in                                         schizophrenia     

                                       Silvana Galderisi, Italy

14:00 – 14:30 Treatment of negative symptoms in schizophrenia

                                                                          W. Wolfgang Fleischhacker, Austria

14:30 – 14:45 Discussion and Closing

13:15-14:45                                 PADIGLIONE SPADOLINI HALL E  


Forum on Schizophrenia Management: Are We Addressing the Mental AND Physical Wellbeing of our Patients?

Moderator:      Prof Peter Haddad

Speakers:         Dr Oliver Howes

                         Prof Thomas Mueller

                         Dr Dan Cohen

                         Dr Lars Hansen

13:15-14:45 ​                                 PADIGLIONE SPADOLINI HALL H


From Mood to Function: Consequences of Major Depressive Disorder (MDD)

Chair:               Mario Maj, Italy

13:15 – 13:20  Chair's introduction                                                Mario Maj, Italy

13:20 – 13:40  Depression is more than just low mood 

                                                                                    Koen Demyttenaere, Belgium

13:40 – 14:00  Why and how should we assess cognitive dysfunction in depression?                                                                                                 Roger McIntyre, Canada

14:00 – 14:20   Functional impairment in MDD: real-world evidence of the                                          consequences of cognitive dysfunction 

                                                                                          Bernhard Baune, Australia

14:20 – 14:40   Questions from the audience 

14:40 – 14:45  Chair's closing remarks                                               Mario Maj, Italy

PRODUCT THEATRE                               SUPPORTED BY JANSSEN

9:30 – 10:00 | EXHIBITION AREA

A Novel 4-per-Year Therapy in the Management of Schizophrenia

Speaker:                     Paz García-Portilla González, Spain

This session will provide information on paliperidone palmitate 3-monthly (PP3M), the novel 3-monthly treatment for schizophrenia, including practical real-world experience from an HCP perspective 


13:15-14:45                                PADIGLIONE CAVANIGLIA HALL A 

INDUSTRY SESSION                                SUPPORTED BY JANSSEN 

Schizophrenia: A Patient's Journey from First Episode to Illness Stabilisation

Chair:                            Mario Maj, Italy

Scientific Committee   Robin Emsley

13:15 – 13:20     Chair's welcome and introduction                        Mario Maj, Italy

13:20 – 13:45     Early diagnosis and treatment for the first episode

                                                                                        Robin Emsley, South Africa

13:45 – 14:10     Communication with patients and carers to optimize long-term                                  treatment to prevent relapse                  

                                                                                              Stephen Heres, Germany

14:10 – 14:35 Therapeutic options and real-world data            

                                                                                                         Peter Haddad, UK

14:35 – 14:45 Closing remarks                                                        Mario Maj, Italy

13:15-14:45 ​                               PADIGLIONE CAVANIGLIA HALL B 

INDUSTRY SESSION                                SUPPORTED BY ​ANGELINI

Treatment of Bipolar Disorder: From the Illness Stabilization to the Management of Acute Episode

Chair:             Guy Goodwin

13.15 – 14.00 Treatment of bipolar disorder                           Andrea Fagiolini, Italy

14:00 – 14:45 From the illness stabilization to the management of acute episode                                                                                                        Leonardo Tondo, Italy

13:15-14:45 ​-                                 PADIGLIONE SPADOLINI HALL E 


Optimising Treatment Strategies in Schizophrenia: From Early to Maintenance Phase with Atypical Long-Acting Injectable Antipsychotics (LAI) 

Unrestricted Educational Grant for the Satellite Symposium received from Otsuka Pharmaceutical Italy S.r.l. and Lundbeck Italia SpA

13:15 – 13:30     From remission to recovery in schizophrenia 

B. Carpiniello, Italy

13:30 – 14:00      Early intervention and first episode of schizophrenia

C. Arango, Spain

14:00 – 14:30      Treatment efficacy, quality of life and functioning in chizophrenia:

                             research evidence and strategies for clinical practice

P. Gorwood, France

14:30 – 14:45         Discussion 

13:15-14:45                                  PADIGLIONE SPADOLINI HALL H 

INDUSTRY SESSION                                    SUPPORTED BY PFIZER

Smoking or quitting – what's best for neuropsychiatric patients?

13.15 – 13.20    Welcome and introductions                   Jacqui Thornton, UK, Chair

13.20 – 13.25     Making the best choice for neuropsychiatric patients: To treat or                                not to treat?

Prof Henri-Jean Aubin, France

13.25 – 13.45      Discussion & Debate     Led by Chair

13.45 – 14.00      The smoking cessation policy and treatment landscape - and                                     what's new? 

Gay Sutherland, UK 

Prof Avraham Weizman, Israel

14.00 – 14.20      Discussion & Debate        Led by Chair

14.20 – 14.25       Insights from practice: How to avoid the cycle of failure? 

Tobias Ruther, Germany

14.25 – 14.40         Discussion & Debate     Led by Chair

14.40 – 14.45          Final remarks, close and call to action     Led by Chair

Keep Me Updated